 |
 |

Cardiogenic ShockTreatment by Augmentation With a Pulsatile Assist Device
Steven J. Phillips, MD;
David F. Gordon, MD;
Robert H. Zeff, MD;
Cham Kongtahworn, MD;
Liberato lannone, MD;
Thomas Brown, MD
JAMA. 1978;240(13):1376-1377.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
INTRA-AORTIC balloon pumping has become an accepted mode of threapy for treatment of complicated myocardial infarction.1,2 A percentage of patients who would benefit from intra-aortic balloon pumping cannot have the procedure applied by way of the femoral artery because of severe arteriosclerotic occlusive disease. This can prevent passage of the balloon or result in complications of insertion.3-5 A small group of patients in whom intra-aortic balloon pump can be applied experiences varying degrees of ischemic neuropathy in the leg in which the balloon was inserted. This occurs because subluminal occlusion of the balloon catheter in the femoral artery reduces the flow through that leg. A pulsatile assist device (PAD) was used for diastolic augmentation in a patient in whom an intra-aortic balloon pump could not be inserted.6,7
Report of a Case
A 69-year-old man was transferred from another hospital to Mercy Hospital, Des Moines, Iowa, for intra-aortic
. . . [Full Text PDF of this Article]
Author Affiliations
From the Section of Cardiovascular Medicine and Surgery, Mercy Hospital, Des Moines, Iowa.
Footnotes
Reprint requests to 1047 Fifth Ave, Des Moines, IA 50314 (Dr Phillips).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|